Your browser doesn't support javascript.
loading
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B.
Deng, Maximilian Y; Sturm, Dominik; Pfaff, Elke; Sill, Martin; Stichel, Damian; Balasubramanian, Gnana Prakash; Tippelt, Stephan; Kramm, Christof; Donson, Andrew M; Green, Adam L; Jones, Chris; Schittenhelm, Jens; Ebinger, Martin; Schuhmann, Martin U; Jones, Barbara C; van Tilburg, Cornelis M; Wittmann, Andrea; Golanov, Andrey; Ryzhova, Marina; Ecker, Jonas; Milde, Till; Witt, Olaf; Sahm, Felix; Reuss, David; Sumerauer, David; Zamecnik, Josef; Korshunov, Andrey; von Deimling, Andreas; Pfister, Stefan M; Jones, David T W.
Affiliation
  • Deng MY; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Sturm D; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pfaff E; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Sill M; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stichel D; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Balasubramanian GP; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Tippelt S; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kramm C; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Donson AM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Green AL; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Jones C; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schittenhelm J; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Ebinger M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Schuhmann MU; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Jones BC; Department of Pediatric Oncology and Hematology, Essen University Hospital, Essen, Germany.
  • van Tilburg CM; Division of Pediatric Hematology and Oncology, University Medical Center Goettingen, Goettingen, Germany.
  • Wittmann A; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
  • Golanov A; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
  • Ryzhova M; Division of Molecular Pathology and Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom.
  • Ecker J; Department of Neuropathology, Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen-Stuttgart, Tübingen University Hospital, Tübingen, Germany.
  • Milde T; Department of Pediatric Hematology/Oncology, Children's University Hospital, Tübingen, Germany.
  • Witt O; Department of Neurosurgery, Division of Pediatric Neurosurgery, Tübingen University Hospital, Tübingen, Germany.
  • Sahm F; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Reuss D; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sumerauer D; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • Zamecnik J; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Korshunov A; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
  • von Deimling A; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Resarch Center (DKFZ), Heidelberg, Germany.
  • Jones DTW; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nat Commun ; 12(1): 5530, 2021 09 20.
Article in En | MEDLINE | ID: mdl-34545083
ABSTRACT
Long-term complications such as radiation-induced second malignancies occur in a subset of patients following radiation-therapy, particularly relevant in pediatric patients due to the long follow-up period in case of survival. Radiation-induced gliomas (RIGs) have been reported in patients after treatment with cranial irradiation for various primary malignancies such as acute lymphoblastic leukemia (ALL) and medulloblastoma (MB). We perform comprehensive (epi-) genetic and expression profiling of RIGs arising after cranial irradiation for MB (n = 23) and ALL (n = 9). Our study reveals a unifying molecular signature for the majority of RIGs, with recurrent PDGFRA amplification and loss of CDKN2A/B and an absence of somatic hotspot mutations in genes encoding histone 3 variants or IDH1/2, uncovering diagnostic markers and potentially actionable targets.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Gene Amplification / Cyclin-Dependent Kinase Inhibitor p16 / Receptor, Platelet-Derived Growth Factor alpha / Cyclin-Dependent Kinase Inhibitor p15 / Glioma / Neoplasm Recurrence, Local Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Gene Amplification / Cyclin-Dependent Kinase Inhibitor p16 / Receptor, Platelet-Derived Growth Factor alpha / Cyclin-Dependent Kinase Inhibitor p15 / Glioma / Neoplasm Recurrence, Local Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Type: Article Affiliation country: Germany